Your browser doesn't support javascript.
loading
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.
Li, Jingmei; Lindström, Linda S; Foo, Jia N; Rafiq, Sajjad; Schmidt, Marjanka K; Pharoah, Paul D P; Michailidou, Kyriaki; Dennis, Joe; Bolla, Manjeet K; Wang, Qin; Van 't Veer, Laura J; Cornelissen, Sten; Rutgers, Emiel; Southey, Melissa C; Apicella, Carmel; Dite, Gillian S; Hopper, John L; Fasching, Peter A; Haeberle, Lothar; Ekici, Arif B; Beckmann, Matthias W; Blomqvist, Carl; Muranen, Taru A; Aittomäki, Kristiina; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M; Kataja, Vesa; Chenevix-Trench, Georgia; Phillips, Kelly-Anne; McLachlan, Sue-Anne; Lambrechts, Diether; Thienpont, Bernard; Smeets, Ann; Wildiers, Hans; Chang-Claude, Jenny; Flesch-Janys, Dieter; Seibold, Petra; Rudolph, Anja; Giles, Graham G; Baglietto, Laura; Severi, Gianluca; Haiman, Christopher A; Henderson, Brian E; Schumacher, Fredrick; Le Marchand, Loic; Kristensen, Vessela; Alnæs, Grethe I Grenaker.
Afiliação
  • Li J; 1] Human Genetics, Genome Institute of Singapore, 60 Biopolis Street 02-01, Singapore 138672, Singapore [2] Saw Swee Hock School of Public Health, National University of Singapore, MD3, 16 Medical Drive, Singapore 117597, Singapore [3].
  • Lindström LS; 1] Department of Surgery, University of California at San Francisco (UCSF), San Francisco, California 94143, USA [2] Department of Biosciences and Nutrition, Karolinska Institutet and University Hospital, SE-171 77 Stockholm, Sweden [3].
  • Foo JN; Human Genetics, Genome Institute of Singapore, 60 Biopolis Street 02-01, Singapore 138672, Singapore.
  • Rafiq S; Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton SO16 6YD, UK.
  • Schmidt MK; 1] Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands [2] Division of Molecular Pathology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands.
  • Pharoah PD; 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK [2] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK.
  • Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
  • Van 't Veer LJ; Division of Molecular Pathology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands.
  • Cornelissen S; Division of Molecular Pathology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands.
  • Rutgers E; Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
  • Southey MC; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, 5th floor, West Wing, Medical Building 181, Melbourne, Victoria 3010, Australia.
  • Apicella C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia.
  • Dite GS; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia.
  • Hopper JL; 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Department of Health Science and Services, Graduate School of Public Health, Seoul National University, 1 Gwa
  • Fasching PA; 1] University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Universitätsstrasse 21-23, 91054 Erlangen, Germany [2] Division of Hematology and Oncology, Department of Medicine, David Geffen School of
  • Haeberle L; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Universitätsstrasse 21-23, 91054 Erlangen, Germany.
  • Ekici AB; Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Schlossplatz 4, 91054 Erlangen, Germany.
  • Beckmann MW; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Universitätsstrasse 21-23, 91054 Erlangen, Germany.
  • Blomqvist C; Department of Oncology, University of Helsinki and Helsinki University Central Hospital, FI-00029 HUS Helsinki, Finland.
  • Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FI-00029 Helsinki, Finland.
  • Aittomäki K; Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FI-00029 Helsinki, Finland.
  • Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-17177, Sweden.
  • Margolin S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm SE-17177, Sweden.
  • Mannermaa A; 1] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Yliopistonranta 1C, FI-70211 Kuopio, Finland [2] Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [3] Cancer Center, Kuopio University Hospital,
  • Kosma VM; 1] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Yliopistonranta 1C, FI-70211 Kuopio, Finland [2] Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [3] Cancer Center, Kuopio University Hospital,
  • Hartikainen JM; 1] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Yliopistonranta 1C, FI-70211 Kuopio, Finland [2] Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [3] Cancer Center, Kuopio University Hospital,
  • Kataja V; 1] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Yliopistonranta 1C, FI-70211 Kuopio, Finland [2] Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland [3] Jyväskylä Central Hospital, Keskussairaalantie 19, 40620 Jyväskylä
  • Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, Queensland 4006, Australia.
  • Phillips KA; 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, St Andrews Place East, East Melbourne, V
  • McLachlan SA; Department of Oncology, St Vincent's Hospital Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, Australia.
  • Lambrechts D; 1] Vesalius Research Center (VRC), VIB, Herestraat 49, 3000 Leuven, Belgium [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Thienpont B; 1] Vesalius Research Center (VRC), VIB, Herestraat 49, 3000 Leuven, Belgium [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Smeets A; Multidisciplinary Breast Center, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Wildiers H; Multidisciplinary Breast Center, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Flesch-Janys D; 1] Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany [2] Department of Cancer Epidemiology/Clinical Cancer Registry, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany [3] Institute for Medical Biomet
  • Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Giles GG; 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, Cancer Council Victoria, 1 Rathdowne Street, Melbourne, Victoria 3053, Australia.
  • Baglietto L; 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, Cancer Council Victoria, 1 Rathdowne Street, Melbourne, Victoria 3053, Australia.
  • Severi G; 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, Cancer Council Victoria, 1 Rathdowne Street, Melbourne, Victoria 3053, Australia.
  • Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 San Pablo Street, Los Angeles, California 90033, USA.
  • Henderson BE; University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, Hawaii 96813, USA.
  • Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 San Pablo Street, Los Angeles, California 90033, USA.
  • Le Marchand L; University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, Hawaii 96813, USA.
  • Kristensen V; 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
  • Alnæs GI; 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway
Nat Commun ; 5: 4051, 2014 Jun 17.
Article em En | MEDLINE | ID: mdl-24937182
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 2 / Neoplasias da Mama / Marcadores Genéticos / Tratamento Farmacológico Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 2 / Neoplasias da Mama / Marcadores Genéticos / Tratamento Farmacológico Idioma: En Ano de publicação: 2014 Tipo de documento: Article